Pronivel-IV
Epoetin Alfa
PRONIVEL IV
4000 I.U/ML – Solution for Injection (IV/SC)
TO LIVE WELL, USE PRONIVEL
SIGNIFICANT INCREASES BBC PRODUCTION
DECREASE TRANSFUSION REQUIREMENT
REDUCES CARDIOVASCULAR EVENT & ASSOCIATED MORTALITY IN CKD PATIENTS
SIGNIFICANTLY IMPROVES QUALITY OF LIFE CKD PATIENTS
TO LIVE WELL, USE PRONIVEL
INDICATIONS
Indicated for the treatment of symptomatic anemia associated with chronic renol failure (CRF):
In adults with renal insufficiency not yet undergoing dialysis for the treatment of severe anemia of renal origin accompanied by clinical symtoms in patients.
Formulation
Pronivel 2,000 I.U. Each prefilled syringe of 1 ml contains:
| Recombinant human erythropole in alpha (rHEPO alpha) 2,000 I.U.Exclpients: | Sodium chloride | Monohydrate Monohydrate monosodium phosphate | Water for Injection q.s. to |
|---|---|---|---|
| Human serum albumin 2.5 mg; | 5.84 mg | 1,987 mg | 1.9. ml |
Therapeutic action:
Anti-anemia hormonal agent, Hernatopottic agent, Erythropolesis stimulant agent.
ATC BO3XAQ1
View Complete Product Information
Epoetin Alfa
PRONIVEL IV
4000 I.U/ML - Solution for Injection (IV/SC) TO LIVE WELL, USE PRONIVEL SIGNIFICANT INCREASES BBC PRODUCTION DECREASE TRANSFUSION REQUIREMENT REDUCES CARDIOVASCULAR EVENT & ASSOCIATED MORTALITY IN CKD PATIENTS SIGNIFICANTLY IMPROVES QUALITY OF LIFE CKD PATIENTS TO LIVE WELL, USE PRONIVELDownload Patient Information Leaflet
Download patient information leaflet Click here
